SE0011205202
SE0011205202
Vitrolife AB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.440.000.000 | 3.609.000.000 | 4.7% |
| Cost of Revenue | 1.443.000.000 | 1.470.000.000 | 1.8% |
| Gross Profit | 1.997.000.000 | 2.139.000.000 | 6.6% |
| 1.423.000.000 | 1.347.000.000 | 5.6% | |
| Operating Income | 574.000.000 | 792.000.000 | 27.5% |
| Pretax Income | -4.886.000.000 | 674.000.000 | 824.9% |
| Net Income Common Stockholders | -5.012.000.000 | 513.000.000 | 1077.0% |
| -- | -- | -- | |
| -- | -- | -- |